EQ Stock Analysis: Buy, Sell, or Hold?
EQ - Equillium, Inc. Common Stock
$1.51
0.00 (0.00%)
▲
5d:
+16.15%
30d:
-1.31%
90d:
+7.09%
BUY
MODERATE Confidence
Last Updated: February 3, 2026
Earnings: Mar 26, 2026
Get Alerted When EQ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: EQ shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: EQ shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: EQ is currently trading at $1.51, which is considered extended relative to its 30-day fair value range of $1.14 to $1.47.
Technical Outlook: Technically, EQ is in a strong uptrend. Immediate support is located at $1.10, while resistance sits at $1.57.
Market Sentiment: EQ has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.50 (+65.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, EQ is in a strong uptrend. Immediate support is located at $1.10, while resistance sits at $1.57.
Market Sentiment: EQ has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.50 (+65.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$1.14 -
$1.47
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 65.6% below Wall St target ($2.50)
Fair Price Analysis
30-Day Fair Range
$1.14 -
$1.47
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$1.10
Resistance Level
$1.57
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.34
Wall Street Target
$2.50
(+65.6%)
Revenue Growth (YoY)
-52.3%
Last updated: February 04, 2026 12:11 AM ET
Data refreshes hourly during market hours. Next update: 1:11 AM
Data refreshes hourly during market hours. Next update: 1:11 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EQ showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 67 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 65 BUY |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 61 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |